Search Results  for 'CLAVIS.OL'

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Aqualis ASA: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

12 Apr 2014 Reuters Investment Profile 12 $20.00

Wright Investors Service Comprehensive Report for Aqualis Asa

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

14 Apr 2014 Wright Reports 42 $75.00

Aqualis ASA (AQUA) - Financial and Strategic SWOT Analysis Review

Aqualis ASA (AQUA) - Financial and Strategic SWOT Analysis Review Summary Aqualis ASA (Aqualis), formerly Clavis Pharma ASA, ...

10 Apr 2014 GlobalData 34 $125.00

Aqualis ASA (AQUA) - Financial and Strategic SWOT Analysis Review

Aqualis ASA (AQUA) - Financial and Strategic SWOT Analysis Review Summary Aqualis ASA (Aqualis), formerly Clavis Pharma ASA, ...

11 Mar 2014 GlobalData 35 $125.00

Company Snapshot - Aqualis ASA

Eight Directors at Aqualis ASA bought/subscribed to 2,040,000 shares at 2.300NOK. The significance rating of the trade was 59...

04 Mar 2014 Directors Deals Ltd. 1 $12.00

Aqualis ASA (AQUA) - Financial and Strategic SWOT Analysis Review

Aqualis ASA (AQUA) - Financial and Strategic SWOT Analysis Review Summary Aqualis ASA (Aqualis) formally Clavis Pharma ASA is...

25 Feb 2014 GlobalData 34 $125.00

Aqualis ASA (AQUA) - Financial and Strategic SWOT Analysis Review

Aqualis ASA (AQUA) - Financial and Strategic SWOT Analysis Review Summary Aqualis ASA (Aqualis) formally Clavis Pharma ASA is...

20 Nov 2013 GlobalData 34 $125.00

Clavis Pharma ASA (CLAVIS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Clavis Pharma ASA (CLAVIS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary Clavis Pharma ASA (Clavis Pha...

23 Jul 2013 GlobalData 59 $250.00

CLAVIS PHARMA - TERMINATION OF COVERAGE

Edison Investment Research is terminating coverage on Clavis Pharma (CLAVIS). Please note you should no longer rely on any pr...

22 Jul 2013 Edison Investment Research 1 $10.00

Clavis Pharma ASA (CLAVIS) - Financial and Strategic SWOT Analysis Review

Clavis Pharma ASA (CLAVIS) - Financial and Strategic SWOT Analysis Review Summary Clavis Pharma ASA (Clavis Pharma) is a clin...

11 Jul 2013 GlobalData 37 $125.00